Extracorporeal treatment in fulminant hepatic failure: Pathophysiologic considerations

International Journal of Artificial Organs

Volumn 25, Issue 10, 2002, Pages 929-934

  Kramer, Ludwig ^a   Bauer, E ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Acute liver failure; Ammonia; Bioartificial; Cerebral herniation; Encephalopathy; Fulminant; Glutamine; Liver support

Indexed keywords

AMMONIA; DETOXIFICATION; NEURODEGENERATIVE DISEASES; PATIENT TREATMENT;

ACUTE LIVER FAILURE; BIOARTIFICIAL; CEREBRAL EDEMA; CEREBRAL HERNIATION; FULMINANT; FULMINANT HEPATIC FAILURES; LIVER SUPPORT; ORTHOTOPIC LIVER TRANSPLANTATION; PATHOPHYSIOLOGIC; PATHOPHYSIOLOGY;

AMINO ACIDS;

AMMONIA; GLUTAMINE; INDOMETACIN; MANNITOL; PROSTAGLANDIN SYNTHASE INHIBITOR;

BIOARTIFICIAL ORGAN; BRAIN EDEMA; BRAIN HERNIA; BRAIN PERFUSION; DEATH; DETOXIFICATION; DISEASE SEVERITY; DRUG EFFECT; EXTRACORPOREAL CIRCULATION; FATALITY; HEMODIALYSIS; HEPATIC ENCEPHALOPATHY; HUMAN; INDUCED HYPOTHERMIA; LIVER FAILURE; LIVER INJURY; LIVER RESECTION; LIVER TRANSPLANTATION; MORTALITY; MULTIPLE ORGAN FAILURE; NERVOUS SYSTEM INJURY; NEUROTOXICITY; NONHUMAN; ORGAN DONOR; ORTHOTOPIC TRANSPLANTATION; PATHOPHYSIOLOGY; REVIEW;

EID: 0036815814     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880202501006     Document Type: Review

References (52)

1. O'Grady JG, Schalm SW, Williams R. Acute liver failure: Redefining the syndromes. Lancet 1993; 342: 273-5.
2. Blei AT. Brain edema and portal-systemic encephalopathy. Liver Transpl 2000; 6 (suppl 1): S14-20.
3. Mullen KD, Birgisson S, Gacad RC, Conjeevaram H. Animal models of hepatic encephalopathy and hyperammonemia. Adv Exp Med Biol 1994; 368: 1-10.
4. Butterworth RF, Giuére JF, Michaud J, Lavoie J, Pomeir-Layargues G. Ammonia: A key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987; 6: 1-12.
5. Basile AS, Saito K, Al-Mardini H, et al. The relationship between plasma and brain quinolinic acid levels and the severity of hepatic encephalopathy. Gastroenterology 1995; 108: 818-23.
6. Mullen KD, Jones EA. Natural benzodiazepines and hepatic encephalopathy. Semin Liver Dis 1996; 16: 255-64.
7. Hughes RD, Williams R. Use of bioartificial and artificial liver support devices. Semin Liver Dis 1996k; 16: 435-44.
8. Gazzard BG, Wetson MJ, Murray-Lyon IM, et al. Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet 1974; 1: 1301-7.
9. Kramer L, Gendo A, Madl C, et al. A controlled study of sorbent suspension dialysis in chronic liver disease and hepatic encephalopathy. Int J Artif Organs 2001; 24: 434-42.
10. O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988; 94: 1186-94.
11. Busse B, Smith MD, Gerlach JC. Treatment of acute liver failure: Hybrid liver support. A critical overview. Langenbecks Arch Surg 1999; 384: 588-99.
12. Conn HO, Lieberthal MM. The Hepatic Coma Syndromes and Lactulose. Baltimore: Williams & Wilkins, 1979.
13. Butterworth RF, Giuére JF, Michaud J, Lavoie J, Pomier-Layargues G. Ammonia: A key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987; 6: 1-12.
14. Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999; 29: 648-6.
15. Madl C, Kramer L, Gendo A, et al. Prognostic accuracy of sensory evoked potentials (SEP) and arterial ammonia in predicting development of cerebral edema and death by cerebral herniation in patients with fulminant hepatic failure (FHF) (abstract). Gastroenterology 118 (suppl): S2: 2400.
16. Stahl J. Studies of the blood ammonia in liver disease. Ann Intern Med 1987; 7: 523-6.
17. Lockwood AH. Metabolic encephalopathies: Opportunities and challenges. J Cereb Blood Flow Metab 1987; 7: 523-6.
18. Hawkins RA, Mans AM. Brain metabolism in encephalopathy caused by hyperammonemia. Adv Exp Med Biol 1994; 368: 11-21.
19. McConnell JR, Antonson DL, Ong CS, et al. Proton spectroscopy of brain glutamine in acute liver failure. Hepatology 1995; 22: 69-74.
20. Cordoba J, Gottstein J, Blei A.T. Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis. J Hepatol 1998; 29:589-94.
21. Kramer L, Tribl B, Gendo A, et al. Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology 2000; 31: 30-4.
22. Lockwood AH. Metabolic encephalopathies: Opportunities and challenges. J Cereb Blood Flow Metab 1987; 7: 523-6.
23. Larsen FS, Strauss G, Knudsen GM, Herzog TM, Hansen BA, Secher NH. Cerebral perfusion, cardiac output, and arterial pressure in patients with fulminant hepatic failure. Crit Care Med 2000; 28: 996-1000.
24. Blei AT, Olafsson SM, Therrien G, Butterworth R. Ammonia-induced cerebral edema and intracranial hypertension in rats after portocaval anastomosis. Hepatology 1994; 19: 80-7.
25. Wendow JA, Harrison PM, Keys R, Williams R. Cerebral blood flow and metabolism in fulminant liver failure. Hepatology 1994; 19: 1407-13.
26. Larsen FS, Gottstein J, Blei AT. Cerebral hyperemia and nitric oxide synthase in rats with ammonia-induced brain edema. J Hepatol 2001; 34: 548-54.
27. Chung C, Gottstein J, Blei AT. Indomethacin prevents ammonia - Induced brain edema in rats after portocaval anastomosis. Hepatology 2001; 34: 249-54.
28. Clemmesen JO, Hansen BA, Larsen FS. Indomethacin normalizes intracranial pressure in acute liver failure: A 23-year old woman treated with indomethacin. Hepatology 1997; 25: 1423-6.
29. Jalan R, Olde Damink SWM, Deutz NEP, Jee A, Hayes PC. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 1999; 354: 1164-8.
30. Whitelaw A, Bridges S, Leaf A, Evans D. Emergency treatment of neonatal hyperamonaemic coma with mild systemic hypothermia. Lancet 2001; 358: 36-8.
31. Ronaldo N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000; 32: 734-9.
32. Takada Y, Ishiguro S, Fukunaga K, et al. Increased intracranial pressure in a porcine model of fulminant hepatic failure using amatoxin and endotoxin. J Hepatol 2001; 34: 825-31.
33. Shi Q, Gaylor JD, Cousins R, Plevris J, Hayes PC, Grant MH. The effects of serum from patients with acute liver failure on the growth and metabolism of Hep G2 cells. Artif Organs 1998; 12: 1023-30.
34. Rozga J, Podesta L, LePage E, et al. Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet 1993; 342: 898-9.
35. Olafsson S, Gottstein J, Blei AT. Brain edema and intracranial hypertension in rats after total hepatectomy. Gastroenterology 1995; 108: 1097-103.
36. Ellis AJ, Wendon J, William R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: A controlled clinical trial. Hepatology 2000; 32: 536-41.
37. Marguilies JE, Thompson RC, Demetriou AA. Aquaporin-4 water channel is up-regulated in the brain in fulminant hepatic failure (Abstract). Hepatology 1999; 30 (suppl 2): S938.
38. Lee WJ, Hawkins RA, Vina JR, Peterson DR. Glutamine transport by the blood-brain barrier: A possible mechanism for nitrogen removal. Am J Physiol 1998; 274: C1101-7.
39. Bender AS, Norenberg MD. Effect of benzodiazepines and neurosteroids on ammonia-induced swelling in cultured astrocytes. J Neurosci Res 1998; 54: 673-80.
40. Abraham RB, Szold O, Merhav H, et al. Rapid resolution of brain edema and improved cerebral perfusion pressure following the molecular adsorbent recycling system in acute liver failure patients. Transplant Proc 2001; 33: 2897-9.
41. Chen SC, Mullon C, Kahaku E, et al. Treatment of severe liver failure with a bioartificial liver. Ann N Y Acad Sci 1997; 831: 350-60.
42. Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 1996; 334: 1209-15.
43. Cordoba J, Blei AT, Mujais S. Determinants of ammonia clearance by hemodialysis. Artif Organs 1996; 20: 800-3.
44. Uribe M, Campollo O, Vargas F, et al. Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: A double-blind, randomized clinical trial. Hepatology 1987; 7: 639-43.
45. Rose C, Michalak A, Rao KV, Quack G, Kircheis G, Butterworth RF. L-ornithine-L-aspartate lowers plasma and CSF ammonia and prevents cerebral edema in rats with acute liver failure. Hepatology 1999; 30: 636-40.
46. Kramer L, Gendo A, Madl C, et al. Biocompatibility of a cuprophane charcoal-based detoxification device in cirrhotic patients with hepatic encephalopathy. Am J Kidney Dis 2000; 36: 1193-1200.
47. Baquerizo A, Myoyan A, Kearns-Jonker M, et al. Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: An ex vivo model of pig to human xenotransplantation. Transplantation 1999; 67: 5-18.
48. Nyberg SL, Misra SP. Hepatocyte liver-assist systems - A clinical update. Mayo Clin Proc 1998; 73: 765-71.
49. Martin U, Kiessig V, Blusch JH, et al. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet 1998; 352: 692-4.
50. Abouna GM, Ganguly PK, Hamdy HM, Jabur SS, Tweed WA, Costa G. Extracorporeal liver perfusion system for successful hepatic support pending liver regeneration or liver transplantation: A pre-clinical controlled trial. Transplantation 1999; 67: 1576-83.
51. Miwa S, Hashikura Y, Mita A, et al. Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure. Hepatology 1999; 30: 1521-6.
52. Streetz K, Leifeld L, Grundmann D, et al. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 2000; 119: 446-60.